Christopher Kenney

Chief Tech/Sci/R&D Officer bij XENON PHARMACEUTICALS INC.

Vermogen: - $ op 31-03-2024

Health Technology

Actieve functies van Christopher Kenney

Bedrijven	Functie	Begin	Einde
XENON PHARMACEUTICALS INC.	Chief Tech/Sci/R&D Officer	23-08-2021	-

Bedrijven	Functie	Begin	Einde
Cadent Therapeutics, Inc. Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA.	Chief Tech/Sci/R&D Officer	01-01-2019	01-12-2020
ACORDA THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	01-01-2016	01-01-2019
Biotie Therapies, Inc.	Chief Tech/Sci/R&D Officer	01-01-2013	01-01-2016

Internationaal

Verenigde Staten	4
Canada	2

Operationeel

Chief Tech/Sci/R&D Officer

Sectoraal

Health Technology

Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Beursgenoteerde bedrijven	2
ACORDA THERAPEUTICS, INC.	Health Technology
XENON PHARMACEUTICALS INC.	Health Technology

Bedrijven in privébezit	2
Cadent Therapeutics, Inc. Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA.	Health Technology
Biotie Therapies, Inc.

Bedrijven in privébezit

Health Technology

Biotie Therapies, Inc.